Pardes Chana-Karkur, Israel

Yulia Matiuhin

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 6.5

ph-index = 1


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yulia Matiuhin: Innovator in Therapeutic Solutions

Introduction

Yulia Matiuhin is a prominent inventor based in Pardes Chana-Karkur, Israel. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic solutions for various medical conditions. With a total of 3 patents, her work focuses on innovative approaches to treating diseases.

Latest Patents

One of her latest patents is titled "Bacteriophage for Modulating Inflammatory Bowel Disease." This patent discloses bacteriophage compositions and their therapeutic uses, specifically targeting bacterial strains associated with inflammatory bowel disease. The bacteriophage is capable of lysing these strains, thereby modulating the disease. Another notable patent is "Inhalable Liquid Formulations of DNase I." This invention pertains to an inhalable pharmaceutical composition for pulmonary administration, which includes human DNase I and a liquid carrier. It also covers methods and devices for therapeutic use in inhalation.

Career Highlights

Throughout her career, Yulia has worked with notable organizations, including Protalix Ltd. and Keio University. Her experience in these institutions has allowed her to advance her research and contribute to the development of innovative therapeutic solutions.

Collaborations

Yulia has collaborated with esteemed colleagues such as Yoseph Shaaltiel and Uri Hanania. These partnerships have further enriched her research and innovation efforts.

Conclusion

Yulia Matiuhin stands out as a dedicated inventor in the biotechnology field, with her patents reflecting her commitment to improving health outcomes through innovative therapies. Her work continues to inspire advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…